State-of-the-art oncological surgery for the patient with colon cancer

The incidents of colon cancer are rising worldwide, and the mortality is the second highest of any cancer in the western world. Within the recent years, huge developments have been made in the understanding of the disease and treatment of patients with colon cancer. Surgery is the primary curative treatment modality and recent research has confirmed that the variation in short- and long-term mortality is related to the perioperative and surgical treatment quality. 
 
After having to cancel ZSF2020 due to the Covid-19 pandemic, we look forward, now more than ever, to sharing with you a day with focus on colon cancer and discussing together the new developments in the multidisciplinary treatment of this disease. We will have the pleasure of including in our program leading experts to put a spotlight on the essential aspects of the diagnosis as well as the anesthesiological, surgical and oncological treatment options for the patient with colon cancer. A preliminary program will be announced soon. The scene will be set by patients who have undergone treatment for colon cancer and three operations, streamed live from Zealand University Hospital, will fuel our discussions during the day. In a parallel nurses’ session, speakers from Sweden, Belgium, the Netherlands and Denmark will explore the opportunities and challenges of pre- and postoperative relations with patients.
 
Join us on March 19 and participate in the lively discussions on the future aspects of the improvement of short- and long-term outcomes after colon cancer surgery. We look forward to welcoming you in Copenhagen!
 

Sincerely.

Henrik Møller Head of Department, Chief Surgeon  Department of Surgery Zealand University Hospital		Ismail Gögenur Professor, Chief Surgeon  Department of Surgery Zealand University Hospital and Copenhagen University